21.10.Z - Manufacture of basic pharmaceutical products
10.89.Z - Production of other food products, not elsewhere classified
46.45.Z - Wholesale trade of perfumes and cosmetics
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.11.Z - Advertising agency activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,2 | -0,2 | 0,2 | 186,6 |
EBITDA | 0,7 | 0,5 | 0,6 | 39,8 |
Short time liabilities | 1,3 | 1,5 | 0,9 | -39,9 |
Equity capital | 0,1 | -0,1 | 0 | 144,9 |
Operating profit (EBIT) | 0,7 | 0,4 | 0,6 | 38,2 |
Assets | 1,5 | 1,4 | 0,9 | -31,6 |
Net profit (loss) | -0,2 | -0,2 | 0,2 | 174 |
Cash | 0,7 | 0,1 | 0,1 | -21,5 |
Net income from sale | 4,8 | 4,4 | 3,6 | -18 |
Liabilities and provisions for liabilities | 1,4 | 1,5 | 0,9 | -39,9 |
Working assets | 1,5 | 1,3 | 0,9 | -30,7 |
Depreciation | 0 | 0 | 0 | 129,3 |
% | % | % | p.p. | |
Profitability of capital | -225,2 | 195,8 | 322,8 | 127 |
Equity capital to total assets | 6,9 | -7,9 | 5,2 | 13,1 |
Gross profit margin | -4,8 | -4,8 | 5,1 | 9,9 |
EBITDA Margin | 15 | 10,3 | 17,6 | 7,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 102 | 122 | 89 | -33 |
Current financial liquidity indicator | 1.1141685247421265 | 0.9072563052177429 | 1.0468906164169312 | 0,1 |
Net dept to EBITDA | -0.9036576747894287 | -0.2626939117908478 | -0.1474597007036209 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane